Pharmacologic inhibition of lactate production prevents myofibroblast differentiation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacologic inhibition of lactate production prevents myofibroblast differentiation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Volume 309, Issue 11, Pages L1305-L1312
Publisher
American Physiological Society
Online
2015-09-26
DOI
10.1152/ajplung.00058.2015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nintedanib and Pirfenidone. New Antifibrotic Treatments Indicated for Idiopathic Pulmonary Fibrosis Offer Hopes and Raises Questions
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer
- (2013) William R. Schelman et al. INVESTIGATIONAL NEW DRUGS
- Gossypol acetic acid induces apoptosis in RAW264.7 cellsviaa caspase-dependent mitochondrial signaling pathway
- (2013) Sijun Deng et al. Journal of Veterinary Science
- Gossypol induces apoptosis in ovarian cancer cells through oxidative stress
- (2013) Jia Wang et al. Molecular BioSystems
- Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo
- (2013) JIE LIN et al. ONCOLOGY REPORTS
- Lactic Acid Is Elevated in Idiopathic Pulmonary Fibrosis and Induces Myofibroblast Differentiation via pH-Dependent Activation of Transforming Growth Factor-β
- (2012) Robert Matthew Kottmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancer
- (2011) G. Sonpavde et al. ANNALS OF ONCOLOGY
- Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer
- (2011) Neal Ready et al. Journal of Thoracic Oncology
- Liposomes Containing (-)-Gossypol-Enriched Cottonseed Oil Suppress Bcl-2 and Bcl-xL Expression in Breast Cancer Cells
- (2011) Hong Li et al. PHARMACEUTICAL RESEARCH
- Inhibition kinetics of NAD-linked enzymes by gossypol acetic acid
- (2010) M. Ikeda ANDROLOGIA
- Gossypol Induces Apoptosis by Activating p53 in Prostate Cancer Cells and Prostate Tumor-Initiating Cells
- (2010) S. R. Volate et al. MOLECULAR CANCER THERAPEUTICS
- Electrophilic Peroxisome Proliferator–Activated Receptor-γ Ligands Have Potent Antifibrotic Effects in Human Lung Fibroblasts
- (2009) Heather E. Ferguson et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
- (2009) G. Liu et al. CLINICAL CANCER RESEARCH
- Determinants of initiation and progression of idiopathic pulmonary fibrosis
- (2009) Robert Matthew KOTTMANN et al. RESPIROLOGY
- Integrins and the activation of latent transforming growth factor β1 – An intimate relationship
- (2008) P WIPFF et al. EUROPEAN JOURNAL OF CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started